Biosearch Technologies Licenses Access to the New CDC "PDM" H1N1 Signatures

Posted on Thu, Nov 18, 2010 @ 08:08 AM

ValuPanel ReagentsBiosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has licensed access to the new “pdm” H1N1 signatures from Centers for Disease Control and Prevention (CDC).  The new “pdm” panel is optimized to achieve enhanced sensitivity and specificity for H1N1 specimen.

To read the entire story, read the full press release.

Topics: Announcement, Biodefense

Subscribe to our blog

About Biosearch Technologies

As the inventor of the BHQ dyes, Biosearch Technologies synthesizes sophisticated oligos for real time qPCR, molecular diagnostics, and more!  Visit our home page to view our products and services.

Follow @BiosearchTech on Twitter

Become a Fan on Facebook!